Laurie Keating is Director of Immuneering Corp. Currently has a direct ownership of 14,000 shares of IMRX, which is worth approximately $29,540. The most recent transaction as insider was on May 16, 2022, when has been sold 7,000 shares (Class A Common Stock) at a price of $5.0 per share, resulting in proceeds of $35,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14K
0% 3M change
0% 12M change
Total Value Held $29,540

LAURIE KEATING Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2022
BUY
Open market or private purchase
$35,000 $5.0 p/Share
7,000 Added 33.33%
14,000 Class A Common Stock
Aug 03 2021
BUY
Open market or private purchase
$105,000 $15.0 p/Share
7,000 Added 50.0%
7,000 Class A Common Stock

Also insider at

ALNY
ALNYLAM PHARMACEUTICALS, INC. Healthcare
IMGO
Imago BioSciences, Inc. Healthcare
PEPG
PepGen Inc. Healthcare
LK

Laurie Keating

Director
Cambridge, MA

Track Institutional and Insider Activities on IMRX

Follow Immuneering Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMRX shares.

Notify only if

Insider Trading

Get notified when an Immuneering Corp insider buys or sells IMRX shares.

Notify only if

News

Receive news related to Immuneering Corp

Track Activities on IMRX